Published: March 23, 2021 By

On February 24, 2021,聽精品SM在线影片 regenerative tissue spinout won first place and $20,000 after pitching聽their next generation dermal filler technology at聽the聽.

TissueForm seeks聽to improve聽quality-of-life outcomes at lower costs for patients suffering from tissue disease, damage, or aging through stem cell and matrix-based therapies. The company鈥攆ounded by聽Jeanne Barthold, PhD, and 精品SM在线影片 Mechanical Engineering Associate Professor聽Corey Neu鈥攊s no stranger to the pitch competition circuit.听

罢颈蝉蝉耻别贵辞谤尘听won $125,000 in Venture Partners' 2018 Lab Venture Challenge聽and took home multiple awards and more than $20,000 as the Women's Entrepreneurship Prize Winner, Research & Development (R&D) Track winner and third runner-up in 精品SM在线影片's New Venture Challenge 11.听

TissueForm has been working with Venture Partners for the last five years on聽commercialization strategies by聽securing IP and funding, advising with mentors, and attending entrepreneurial events and customer聽discovery workshops like Research-to-Market (R2M).

The company's聽focus in the near term is to commercialize its first product, NatruDerme. TissueForm is looking to raise seed financing alongside non-dilutive federal and state grants to enable critical FDA-pathway defined manufacturing and pre-clinical studies.听

"This聽will enable TissueForm to grow our team and complete the first step towards FDA device approval: pre-clinical safety and toxicity testing," said Barthold.

Learn More